This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations of Hong Sheng in Hepatitis B Treatment
Introduction
Hong Sheng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has led to the development of novel compounds aimed at combating Hepatitis B virus infection.
Latest Patents
Hong Sheng holds a patent for "4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection." This invention provides novel compounds characterized by a specific general formula, which includes various components as described in the patent documentation. The compounds, along with their compositions and methods of use, represent a significant advancement in therapeutic options for Hepatitis B.
Career Highlights
Throughout his career, Hong Sheng has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and Allnex Belgium S.A. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Hong Sheng has collaborated with esteemed colleagues, including Lei Guo and Xianfeng Lin. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
In summary, Hong Sheng's contributions to the field of medicine, particularly through his patent for Hepatitis B treatment, highlight his role as an innovative inventor. His work continues to impact the pharmaceutical landscape positively.